subcutaneous port. Complications can include infection, malfunction of the catheter and occasionally intestinal blockage.
Intraperitoneal chemotherapy is generally given monthly for six months. Although preliminary results are encouraging it has been tested in a small number of women who have been followed only for a short time, so it is still considered investigational. Large trials are now under way to compare the effectiveness of intraperitoneal versus intravenous chemotherapy.
Chemotherapy can cause hair loss, nausea and vomiting, infection or bleeding because of bone marrow toxicity, and damage to the heart, kidneys, nerves and liver.
